Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

BACKGROUND: Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. METHODS: We conducted a multicenter, randomized, open-label, three-group, controlled trial involving...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :N Engl J Med
Главные авторы: Cavalcanti, Alexandre B., Zampieri, Fernando G., Rosa, Regis G., Azevedo, Luciano C.P., Veiga, Viviane C., Avezum, Alvaro, Damiani, Lucas P., Marcadenti, Aline, Kawano-Dourado, Letícia, Lisboa, Thiago, Junqueira, Debora L. M., de Barros e Silva, Pedro G.M., Tramujas, Lucas, Abreu-Silva, Erlon O., Laranjeira, Ligia N., Soares, Aline T., Echenique, Leandro S., Pereira, Adriano J., Freitas, Flávio G.R., Gebara, Otávio C.E., Dantas, Vicente C.S., Furtado, Remo H.M., Milan, Eveline P., Golin, Nicole A., Cardoso, Fábio F., Maia, Israel S., Hoffmann Filho, Conrado R., Kormann, Adrian P.M., Amazonas, Roberto B., Bocchi de Oliveira, Monalisa F., Serpa-Neto, Ary, Falavigna, Maicon, Lopes, Renato D., Machado, Flávia R., Berwanger, Otavio
Формат: Artigo
Язык:Inglês
Опубликовано: Massachusetts Medical Society 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7397242/
https://ncbi.nlm.nih.gov/pubmed/32706953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2019014
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы